COMPASS Pathways plc

CMPS

$13.46

Updated: 24/09/2026, 16:34:14

Market Cap

$1.82B

Sector

Healthcare

Industry

Biotechnology

Country

Stock valuation chart

One-year closing share-price history for CMPS

Company Profile

COMPASS Pathways plc is a mental healthcare company with a primary presence in the United Kingdom and the United States. Established in 2020 and headquartered in London, UK, the firm focuses on developing novel treatments. Its key product is COMP360, an investigational psilocybin therapy. This therapy has advanced through Phase IIb clinical trials for treatment-resistant depression and is currently undergoing Phase II trials for post-traumatic stress disorder. The company previously operated under the name COMPASS Rx Limited before rebranding to COMPASS Pathways plc in August 2020.

USD

NASDAQ

CEO: Kabir Kumar Nath

Employees: 156

https://compasspathways.com

Asset Summaries

Latest generated summaries for CMPS

No summaries found.

Detailed business

Structured knowledge from the latest official annual filing.

No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.

Full company information

Latest profile, trading, valuation, and identifier data stored for CMPS.

Share price: $13.46
Market cap: $1.82B
Exchange: NASDAQ
Currency: USD
CEO: Kabir Kumar Nath
Employees: 156
IPO date: 18/09/2020
Beta: 2.549
Last dividend: $0.00
Day range: $13.04 – $13.77
52-week range: $4.88 – $15.87
1-day performance: -2.11%
1-year performance: 175.82%
Current drawdown (1Y): -15.19%
CIK: 0001816590
CUSIP: 20451W101
ISIN: US20451W1018
Created: 07/12/2025, 03:21:54
Last update: 24/09/2026, 16:34:14

Track COMPASS Pathways plc with an AI analyst

See which prediction-market events move CMPS, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Create a free account See what the world decides next

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News

News linked to CMPS from your Railway `news_articles` table.

COMPASS Pathways plc (CMPS) Q1 2026 Earnings Call Transcript

Seeking Alpha • STOCK • 13/05/2026, 18:00:50

What Makes COMPASS Pathways PLC Sponsored ADR (CMPS) a Strong Momentum Stock: Buy Now?

Zacks Investment Research • STOCK • 22/04/2026, 15:01:25

COMPASS Pathways plc (CMPS) Discusses Positive Phase III Results for COMP360 in Treatment-Resistant Depression Trials Transcript

Seeking Alpha • STOCK • 17/02/2026, 18:14:56